These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 1722452)
1. A study of alpha-fetoprotein in primary liver cancer in Tanzania. Spencer SS; Lindqvist KJ; Nantulya VM East Afr Med J; 1991 Aug; 68(8):595-600. PubMed ID: 1722452 [TBL] [Abstract][Full Text] [Related]
2. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524 [TBL] [Abstract][Full Text] [Related]
3. Assessment of alpha-fetoprotein in chronic HBsAg carriers and in HBsAg negative cirrhosis of the liver. Stránský J; Zichová M; Vodák M Sb Lek; 1993; 94(4):311-5. PubMed ID: 7527585 [TBL] [Abstract][Full Text] [Related]
4. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians. Ola SO; Olubuyide IO; Ayoola EA East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684 [TBL] [Abstract][Full Text] [Related]
5. Clinical implications of alpha-fetoprotein in liver cirrhosis: five-year follow-up study. Harada T; Shigeta K; Noda K; Fukumoto Y; Nishimura H; Mizuta M; Takemoto T Hepatogastroenterology; 1980 Jun; 27(3):169-75. PubMed ID: 6161869 [TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001 [TBL] [Abstract][Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
8. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. McMahon BJ; Bulkow L; Harpster A; Snowball M; Lanier A; Sacco F; Dunaway E; Williams J Hepatology; 2000 Oct; 32(4 Pt 1):842-6. PubMed ID: 11003632 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study on HBsAg, HBcAg and AFP in 104 patients with small liver cancer]. Zhang SP Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):353-6. PubMed ID: 2470564 [TBL] [Abstract][Full Text] [Related]
11. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study. Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185 [TBL] [Abstract][Full Text] [Related]
12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
13. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Cedrone A; Covino M; Caturelli E; Pompili M; Lorenzelli G; Villani MR; Valle D; Sperandeo M; Rapaccini GL; Gasbarrini G Hepatogastroenterology; 2000; 47(36):1654-8. PubMed ID: 11149026 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M; Gama H; Chida N; Ueno Y; Shinzawa H; Takagi T; Toyota T; Takahashi T; Kasukawa R Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya. Mwangi J; Gatei DG East Afr Med J; 1993 Apr; 70(4 Suppl):34-6. PubMed ID: 8223308 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774 [TBL] [Abstract][Full Text] [Related]
17. The low positive rate of serum alpha-fetoprotein levels in hepatitis C virus antibody-positive patients with hepatocellular carcinoma. Furui J; Furukawa M; Kanematsu T Hepatogastroenterology; 1995; 42(5):445-9. PubMed ID: 8751193 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection. Yahalom J; Livni N; Fuks Z; Levij IS Isr J Med Sci; 1985 Jan; 21(1):1-5. PubMed ID: 2579047 [TBL] [Abstract][Full Text] [Related]
19. [Hepatitis B virus infection and hepatocellular carcinoma: indication for a possible causal connection even in non-endemic Switzerland]. Pirovino M; Heer M; Altorfer J; Akovbiantz A; Grob P; Schmid M Schweiz Med Wochenschr; 1983 Jun; 113(22):824-6. PubMed ID: 6192495 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]